Cargando…

Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain

BACKGROUND: Although the first clinical descriptions of Bartonella infection were associated with immunocompromised patient with bacillary angiomatosis, we currently know that this organism is directly involved in diseases affecting a large number of patients, regardless of their immune status. Cat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pons, Immaculada, Sanfeliu, Isabel, Nogueras, María Mercedes, Sala, Montserrat, Cervantes, Manuel, Amengual, M José, Segura, Ferran
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390557/
https://www.ncbi.nlm.nih.gov/pubmed/18452613
http://dx.doi.org/10.1186/1471-2334-8-58
_version_ 1782155322772684800
author Pons, Immaculada
Sanfeliu, Isabel
Nogueras, María Mercedes
Sala, Montserrat
Cervantes, Manuel
Amengual, M José
Segura, Ferran
author_facet Pons, Immaculada
Sanfeliu, Isabel
Nogueras, María Mercedes
Sala, Montserrat
Cervantes, Manuel
Amengual, M José
Segura, Ferran
author_sort Pons, Immaculada
collection PubMed
description BACKGROUND: Although the first clinical descriptions of Bartonella infection were associated with immunocompromised patient with bacillary angiomatosis, we currently know that this organism is directly involved in diseases affecting a large number of patients, regardless of their immune status. Cat scratch disease, hepatic peliosis, and some cases of bacteraemia and endocarditis, are directly caused by some species of the genus Bartonella. The purpose of this study was to determinate the prevalence of IgG antibodies against Bartonella henselae and B. quintana in HIV patients and to identify the epidemiological factors involved. METHODS: Serum samples were collected from HIV patients treated at Hospital de Sabadell. Antibodies to B. henselae and B. quintana from 340 patients were examined by indirect immunofluorescence assay (IFA). Significance levels for univariate statistical test were determined by the Mann-Whitney U test and χ(2 )test. RESULTS: Of 340 patients, 82 were women and 258 men, with a median age of 42.21 ± 10.35 years (range 16–86 years). Seventy-six (22.3%) patients reacted with one or more Bartonella antigens. Of all the factors concerning the seroprevalence rate being studied (age, sex, intravenous drugs use, alcohol consumption, CD4 levels, AIDS, HCV, HBV, residential area), only age was statistically significant. CONCLUSION: A high percentage of HIV patients presents antibodies to Bartonella and is increasing with age.
format Text
id pubmed-2390557
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23905572008-05-21 Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain Pons, Immaculada Sanfeliu, Isabel Nogueras, María Mercedes Sala, Montserrat Cervantes, Manuel Amengual, M José Segura, Ferran BMC Infect Dis Research Article BACKGROUND: Although the first clinical descriptions of Bartonella infection were associated with immunocompromised patient with bacillary angiomatosis, we currently know that this organism is directly involved in diseases affecting a large number of patients, regardless of their immune status. Cat scratch disease, hepatic peliosis, and some cases of bacteraemia and endocarditis, are directly caused by some species of the genus Bartonella. The purpose of this study was to determinate the prevalence of IgG antibodies against Bartonella henselae and B. quintana in HIV patients and to identify the epidemiological factors involved. METHODS: Serum samples were collected from HIV patients treated at Hospital de Sabadell. Antibodies to B. henselae and B. quintana from 340 patients were examined by indirect immunofluorescence assay (IFA). Significance levels for univariate statistical test were determined by the Mann-Whitney U test and χ(2 )test. RESULTS: Of 340 patients, 82 were women and 258 men, with a median age of 42.21 ± 10.35 years (range 16–86 years). Seventy-six (22.3%) patients reacted with one or more Bartonella antigens. Of all the factors concerning the seroprevalence rate being studied (age, sex, intravenous drugs use, alcohol consumption, CD4 levels, AIDS, HCV, HBV, residential area), only age was statistically significant. CONCLUSION: A high percentage of HIV patients presents antibodies to Bartonella and is increasing with age. BioMed Central 2008-05-01 /pmc/articles/PMC2390557/ /pubmed/18452613 http://dx.doi.org/10.1186/1471-2334-8-58 Text en Copyright © 2008 Pons et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pons, Immaculada
Sanfeliu, Isabel
Nogueras, María Mercedes
Sala, Montserrat
Cervantes, Manuel
Amengual, M José
Segura, Ferran
Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
title Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
title_full Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
title_fullStr Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
title_full_unstemmed Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
title_short Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain
title_sort seroprevalence of bartonella spp. infection in hiv patients in catalonia, spain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390557/
https://www.ncbi.nlm.nih.gov/pubmed/18452613
http://dx.doi.org/10.1186/1471-2334-8-58
work_keys_str_mv AT ponsimmaculada seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain
AT sanfeliuisabel seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain
AT noguerasmariamercedes seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain
AT salamontserrat seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain
AT cervantesmanuel seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain
AT amengualmjose seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain
AT seguraferran seroprevalenceofbartonellasppinfectioninhivpatientsincataloniaspain